http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011098315-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9fd3448dff1a31f5b8f3fff654c726a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d599cc749bad9e13497f1d4e474c959b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6498ef88a06d436c04c57fe6ed75856
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a89e56f57329e684f2384b82617c460
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9cfa47575ffcb8d775f0c549c1e1152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bebdb290125a9af2015ab9689a9ab8f
publicationDate 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011098315-A1
titleOfInvention Pharmaceutical compositions of rosuvastatin calcium
abstract This invention is related to pharmaceutical compositions of rosuvastatin or pharmaceutically acceptable salts thereof especially calcium salt with sodium carbonate anhydrous which has effects on dissoltion profiles in 0.1 N HCI medium provided that using of sodium carbonate anhydrous should be presence in the range of from about 0.5% to about 2% by weight.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10434067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016045444-A1
priorityDate 2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007202159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004137054-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451829787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454570538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248252387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450470952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6439133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23696331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136137898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID769

Total number of triples: 50.